CDKN2A and esophageal squamous cell carcinoma: We also observed that CCND1 and CDKN2A, encoding two key molecules for cell cycling, were rarely altered in ESC (Additional file 2: Table S2), while CCND1 amplification and CDKN2A mutations were found in 30% and 20% of ESCC patients, respectively [15].